IP Library Granted Patent US 12,037,634
Granted Patent B2
US 12,037,634 · App. 17/353,202 · Granted Jul 16, 2024

Capsule array devices and methods of use

Inventors: Benjamin Hindson (Pleasanton, CA); Serge Saxonov (Oakland, CA); Michael Schnall-Levin (San Francisco, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6806B01J19/0046B01L3/502715B01L3/508B01L3/523C12N15/1065B01L2200/0647B01L2400/0677C12Q2535/122C12Q2563/159
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,037,634
App. No.
17/353,202
Filed
Jun 21, 2021
Granted
Jul 16, 2024
Kind
B2
Art Unit
1634
USPC
506/4
Abstract

This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molecular identifiers within a single unit in preparation for various analysis operations. The device may be useful in a variety of applications and most notably nucleic-acid-based sequencing, detection and quantification of gene expression and single-cell analysis.

Claims (27)

1. A system, comprising:

(i) a bead comprising at least 1,000,000 oligonucleotide barcodes; and

(ii) a microfluidic device comprising:

(a) a first junction of channels configured to form an aqueous mixture comprising the bead comprising the at least 1,000,000 oligonucleotide barcodes and a sample comprising a nucleic acid analyte; and

(b) a second junction of channels configured to contact the aqueous mixture with an immiscible continuous phase, thereby generating a droplet comprising (I) the bead comprising the at least 1,000,000 oligonucleotide barcodes and (II) the nucleic acid analyte.

2. The system of claim 1 , wherein oligonucleotide barcodes of the at least 1,000,000 oligonucleotide barcodes comprise a common barcode sequence.

3. The system of claim 1 , wherein oligonucleotide barcodes of the at least 1,000,000 oligonucleotide barcodes comprise a primer sequence.

4. The system of claim 3 , wherein the primer sequence is a sequencing primer sequence.

5. The system of claim 3 , wherein the primer sequence comprises a sequence configured for random priming.

6. The system of claim 1 , wherein the at least 1,000,000 oligonucleotide barcodes are attached to the bead via a chemical cross-linker.

7. The system of claim 6 , wherein the chemical cross-linker is a disulfide bond.

8. The system of claim 6 , wherein the at least 1,000,000 oligonucleotide barcodes are attached to the bead via a labile moiety.

9. The system of claim 1 , wherein the bead is degradable upon application of a stimulus.

10. The system of claim 9 , wherein the droplet further comprises the stimulus.

11. The system of claim 9 , wherein the stimulus is selected from the group consisting of a biological stimulus, a chemical stimulus, a thermal stimulus, an electrical stimulus, a magnetic stimulus, and a photo stimulus.

12. The system of claim 11 , wherein the stimulus is a chemical stimulus that is a reducing agent.

13. The system of claim 1 , wherein the droplet is an emulsion.

14. The system of claim 13 , wherein the emulsion is a water-in-oil emulsion.

15. The system of claim 1 , wherein the system further comprises the aqueous mixture and the immiscible continuous phase.

16. The system of claim 1 , further comprising the sample.

17. The system of claim 16 , wherein the sample comprises a cell comprising the nucleic acid analyte.

18. The system of claim 17 , wherein the sample comprises a plurality of cells including the cell.

19. The system of claim 1 , wherein the system further comprises the droplet.

20. The system of claim 19 , wherein the droplet comprises cell lysis reagents.

21. The system of claim 19 , wherein the droplet comprises reagents sufficient for conducting an amplification reaction.

22. The system of claim 19 , wherein the droplet comprises a polymerase.

23. The system of claim 1 , wherein one or more of the at least 1,000,000 oligonucleotide barcodes comprises a uracil.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2024
From: SCHNALL-LEVIN, MICHAEL
To: 10X GENOMICS, INC.
Reel/Frame 066967/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2024
From: HINDSON, BENJAMIN; SAXONOV, SERGE
To: 10X TECHNOLOGIES, INC.
Reel/Frame 066967/0768 →
CHANGE OF NAME Recorded Mar 8, 2024
From: 10X TECHNOLOGIES, INC.
To: 10X GENOMICS, INC.
Reel/Frame 066766/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2021
From: HINDSON, BENJAMIN; SAXONOV, SERGE; SCHNALL-LEVIN, MICHAEL
To: 10X GENOMICS, INC.
Reel/Frame 058275/0798 →
Continuity (12)
Continuation 16519863 · Jul 23, 2019
Continuation 15975468 · May 9, 2018
Continuation 15598898 · May 18, 2017
Continuation 14624468 · Feb 17, 2015
Division 13966150 · Aug 13, 2013
Provisional Application 61683192 · Aug 14, 2012
Provisional Application 61737374 · Dec 14, 2012
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 61800223 · Mar 15, 2013
Provisional Application 61840403 · Jun 27, 2013
Provisional Application 61844804 · Jul 10, 2013
Related Publication 20220081704A1 · Mar 17, 2022
Cited By (1)
US 12,312,640